每经AI快讯，普蕊斯1月14日晚间发布公告称，股东上海弘甲私募基金管理有限公司－宁波汇桥弘甲创 业投资合伙企业（有限合伙）持有公司股份约56万股，占公司总股本比例为0.7054%。汇桥弘甲计划自 本公告发布之日起3个交易日后的3个月内以大宗交易方式和/或以集中竞价交易方式减持公司股份不超 过约56万股（占公司总股本比例为0.7054%）。 （记者 张明双） 公司股东张晶持有公司股份约92万股，占公司总股本比例为1.1605%。股东张晶计划自本公告发布之日 起3个交易日后的3个月内以大宗交易方式和/或以集中竞价交易方式减持公司股份不超过约92万股（占 公司总股本比例为1.1605%）。 每经头条（nbdtoutiao）——海利生物增值9倍并购的企业，估值8个月"腰斩"，其第一大客户竟是尚未 成立的公司，离奇的事还不少…… ...

普蕊斯(301257.SZ)公告称，公司股票交易价格连续两个交易日收盘价涨幅偏离值累计超过30%，属于股 票交易异常波动情形。经核实，公司前期披露的信息不存在需要更正、补充之处，未发现近期公共传媒 报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息，公司近期经营情况正常，内外 部经营环境未发生重大变化。股东汇桥弘甲拟减持不超0.71%股份、股东张晶拟减持不超1.16%股份。 ...

证券代码：301257 证券简称：普蕊斯 公告编号：2026-002 普蕊斯（上海）医药科技开发股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 5、经查询，公司控股股东、实际控制人在股票交易异常波动期间不存在买 卖公司股票的行为。 6、经查询，公司不存在违反信息公平披露的其他情形。 三、是否存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据《深圳证券交易所创业板股票 上市规则》等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、 意向、协议等；董事会也未获悉本公司有根据《深圳证券交易所创业板股票上市 规则》等有关规定应予以披露而未披露的、对本公司股票及其衍生品种交易价格 产生较大影响的信息；公司前期披露的信息不存在需要更正、补充之处。 普蕊斯（上海）医药科技开发股份有限公司（以下简称"公司"）股票交易价 格于 2026 年 1 月 13 日、2026 年 1 月 14 日连续两个交易日收盘价涨幅偏离值累 计超过 30%，根据深圳证券交易所的相关规定，属于股票交易异 ...

证券代码：301257 证券简称：普蕊斯 公告编号：2026-001 普蕊斯（上海）医药科技开发股份有限公司 关于公司股东减持股份预披露公告 公司股东上海弘甲私募基金管理有限公司－宁波汇桥弘甲创业投资合伙 企业（有限合伙）、股东张晶保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、普蕊斯（上海）医药科技开发股份有限公司（以下简称"公司"）股东 上海弘甲私募基金管理有限公司－宁波汇桥弘甲创业投资合伙企业（有限合伙） （以下简称"汇桥弘甲"）持有公司股份 557,320 股，占本公司总股本比例 0.7054%。 汇桥弘甲计划自本公告发布之日起 3 个交易日后的 3 个月内以大宗交易方式和/ 或以集中竞价交易方式减持本公司股份不超过 557,320 股（占本公司总股本比例 0.7054%）。 3、减持方式：大宗交易和/或集中竞价交易 4、减持数量及占公司总股本的比例：计划减持本公司股份不超过 557,320 股，不超过本公司总股本比例 0.7054%。 2、公司股东张晶 ...

Group 1 - The healthcare services sector opened with a continuous upward trend, with Puris rising over 14% and reaching a new high during the session [1] - Meiyuan Health achieved a four-day consecutive increase, while New Mileage recorded a two-day consecutive increase [1] - International Medicine hit the daily limit, and companies such as Boteng Co., Zhaoyan New Drug, Nossger, Lanwei Medicine, and Berry Genomics also experienced gains [1]

Core Viewpoint - The healthcare sector has shown a strong upward trend in opening trading, with several companies experiencing significant gains and reaching new highs [1] Group 1: Company Performance - Puris has surged over 14% and reached an intraday high [1] - Meiyuan Health has achieved a four-day consecutive increase [1] - New Mileage has recorded a two-day consecutive increase [1] - International Medicine has hit the daily limit [1] - Boteng Co., Zhaoyan New Drug, Nossger, Lanwei Medical, and Berry Genomics have also seen upward movements [1]

Market Overview - On January 13, the A-share market saw a collective decline in the three major indices, with the Shanghai Composite Index closing at 4163.84 points, down 0.03% [2] - The Shenzhen Component Index fell by 0.31%, and the ChiNext Index decreased by 0.83% [2][3] - A total of 2427 stocks rose while 2862 stocks fell, indicating a mixed market sentiment [3] Sector Performance - The healthcare services, lithium mining, precious metals, and insurance sectors showed strong performance, while sectors such as commercial aerospace, communication equipment, and shipbuilding faced declines [3][4] - Lithium mining stocks experienced a significant surge, with companies like Tibet Summit reaching a 10% limit up, and others like Salt Lake Co. and Ganfeng Lithium rising over 7% [6][7] Lithium Mining Sector - The lithium mining sector saw a notable rally, with the main contract for lithium carbonate futures on the Shanghai Futures Exchange surpassing 170,000 yuan per ton, marking a rise of over 9% [6] - Key stocks in this sector include: - Tibet Summit: 19.49 yuan, up 9.99%, market cap of 17.8 billion yuan - Ganfeng Lithium: 72.83 yuan, up 7.15%, market cap of 144.5 billion yuan - Salt Lake Co.: 34.24 yuan, up 7.13%, market cap of 181.2 billion yuan [7] Insurance Sector - The financial sector was active, with the insurance sector showing strength. China Life Insurance rose over 3%, reaching 50.94 yuan per share, with a market cap of 1.2794 trillion yuan [10] - China Ping An increased by over 2%, priced at 68.92 yuan per share, with a market cap of 1.2034 trillion yuan [12] - Analysts predict that by 2026, new premium income for listed insurance companies will achieve double-digit growth, driven primarily by the bancassurance channel [15] AI Healthcare Sector - AI healthcare stocks were notably active, with several companies hitting the daily limit up. Notable performers included: - Nossg: 76.48 yuan, up 20.01%, market cap of 7.4 billion yuan - Pruis: 72.24 yuan, up 20.00%, market cap of 5.7 billion yuan - Hongbo Medicine: 56.64 yuan, up 20.00%, market cap of 7.9 billion yuan [18] - Nvidia announced a joint investment of $1 billion with Eli Lilly to establish an AI drug laboratory, which is expected to accelerate medical discoveries [17] Precious Metals Sector - The precious metals sector saw a significant rise, with spot gold prices reaching a record high of $4630.28 per ounce [20] - Key stocks in this sector include: - Hunan Silver: 9.21 yuan, up 9.90%, market cap of 26 billion yuan - Xiaocheng Technology: 38.54 yuan, up 8.72%, market cap of 10.6 billion yuan [21]

Market Overview - The A-share market experienced a collective decline in the three major indices, with the Shanghai Composite Index closing at 4163.84 points, down 0.03%, the Shenzhen Component Index down 0.31%, and the ChiNext Index down 0.83% [1] Sector Performance - The market saw 2427 stocks rise, with 81 hitting the daily limit, while 2862 stocks fell. Notably, sectors such as medical services, lithium mining, precious metals, and insurance showed significant gains, while commercial aerospace, communication equipment, and shipbuilding sectors faced declines [2] Lithium Mining Sector - The lithium mining sector saw a strong surge, with stocks like Tibet Summit hitting the daily limit, and companies such as Salt Lake Industry and Ganfeng Lithium rising over 7%. Other companies like Zangge Mining and Tianqi Lithium also saw increases of over 5% [5] - The main contract for lithium carbonate futures on the Shanghai Futures Exchange surpassed 170,000 yuan per ton, marking a rise of over 9% and reaching a new high since October 2023 [7] Insurance Sector - The insurance sector showed resilience, with major players like China Life and Ping An rising over 3% and 2% respectively. China Life's market capitalization reached 1.2794 trillion yuan, while Ping An's reached 1.2034 trillion yuan [10][11] - Analysts predict that new insurance premiums for listed companies will achieve double-digit growth by 2026, driven primarily by the bancassurance channel and the proactive expansion of large insurers [12] AI Medical Sector - The AI medical sector experienced a wave of activity, with stocks like Dian Diagnostics and Nuo Si Ge hitting the daily limit. Nvidia announced a $1 billion investment with Eli Lilly to establish an AI drug laboratory, which is expected to accelerate medical discoveries [13] Precious Metals Sector - The precious metals sector saw a notable rise, with spot gold prices reaching a record high of $4630.28 per ounce. Stocks such as Hunan Silver and Xiaocheng Technology rose over 8%, while other companies like Shandong Gold and Zhongjin Gold also experienced gains [15]

Market Overview - The A-share market opened higher on January 13, with the Shanghai Composite Index up by 0.31%, the Shenzhen Component Index up by 0.36%, and the ChiNext Index up by 0.59% [1] - In the Hong Kong market, all three major indices rose by over 1%, with notable gains in stocks like Alibaba Health, BYD, and Xpeng Motors [1] AI Medical Sector - AI medical stocks showed strong performance, with companies like Hongbo Pharmaceutical, Prusis, and Dian Diagnostics achieving a 20% limit-up, while Meien Health recorded three consecutive trading limits [3][4] - Nvidia announced a $1 billion investment with Eli Lilly to establish an AI drug laboratory over the next five years, focusing on accelerating medical discoveries and production [5] Cultural Media Sector - The cultural media and AIGC sectors also saw significant gains, with Tianlong Group achieving a 20% limit-up, and other companies like People's Daily and Xinhua News also hitting their trading limits [5][6] Commercial Aerospace Sector - The commercial aerospace sector experienced a sharp decline, with stocks like Aerospace Hanyu hitting a 20% limit-down, and other companies such as Aerospace Development and China Satcom also facing significant drops [7][8] - A number of companies, including Aerospace Hanyu and China Satellite, issued risk warnings regarding stock price volatility and potential trading suspensions due to abnormal trading activities [9]

Core Viewpoint - The AI healthcare and pharmaceutical sectors are experiencing significant upward momentum, with multiple stocks reaching their daily limit up. Group 1: Stock Performance - Chinese Health (301408) and Sichuang Medical (300078) both hit the 20% daily limit up [1] - Other stocks such as Xin Ganjiang, Boji Pharmaceutical (300404), Nossger (301333), Puris (301257), and Dian Diagnostics (300244) also reached their daily limit up [1] - Companies like Okon Pharmaceutical, Rongchang Bio, Weining Health (300253), and BGI Genomics (300676) saw their stock prices increase by over 10% [1]